Mirum Pharmaceuticals, Inc. provided earnings guidance for fourth quarter 2023 and full year 2023. For the quarter, company expects total net product sales in range of $69 Million to $71 million,

For the year, company expects tot al revenue in range of $186 Million to $188 Million in total revenue and in range of $178 Million to $180 Million net product sales.